UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, cilt.16, sa.2, ss.108-113, 2006 (Scopus, TRDizin)
The role of 18F-fluorodeoxyglucose positron emission tomography in the staging of lymphoma, response to treatment and early diagnosis of relapses were evaluated in this review. 18F-fluorodeoxyglucose positron emission tomography is the best noninvasive screening method after treatment. However, the findings should be correlated with the clinical data, other radiological methods and biopsy. 18F-fluorodeoxyglucose positron emission tomography is superior to conventional radiological methods in the initial evoluation of Hodgkin lymphoma. 18F-fluorodeoxyglucose positron emission tomography when combined with computed tomography has advantages to both of the separate methods. 18F- fluorodeoxyglucose positron emission tomography is also benecial in defining the radiotherapy area and the planning of the surgical biopsy. Moreover, 18F-fluorodeoxyglucose positron emission tomography is found to be superior to galyum 67 in the literature.